Incidence and attributable costs of ventilator associated pneumonia (VAP) in a tertiary level intensive care unit (ICU) in northern India ScienceDirect JCDR Ventilator associated pneumonia, hospital acquired pneumonia, mul tidrug resistant pathogens, intensive care unit VENTILATOR = LIFE SUPPORT but also VAP RISK. Up to 20% of ventilated patients >48 hrs develop VAP. Mortality? Can reach 50%. Here's what actually matters in ICU rounds Epidemiology of ventilator associated pneumonia in ICU COVID 19 patients: an alarming high rate of multidrug resistant bacteria Journal of Anesthesia, Analgesia and Critical Care Springer Nature Link